Search

Your search keyword '"van Gils, Carla H"' showing total 1,403 results

Search Constraints

Start Over You searched for: Author "van Gils, Carla H" Remove constraint Author: "van Gils, Carla H"
1,403 results on '"van Gils, Carla H"'

Search Results

1. Re-attendance in supplemental breast MRI screening rounds of the DENSE trial for women with extremely dense breasts

2. Reproductive factors and mammographic density within the International Consortium of Mammographic Density: A cross-sectional study

9. The association of age at menarche and adult height with mammographic density in the International Consortium of Mammographic Density

15. Long-term exposure to fine particle elemental components and lung cancer incidence in the ELAPSE pooled cohort

16. Long-term low-level ambient air pollution exposure and risk of lung cancer – A pooled analysis of 7 European cohorts

17. Healthy lifestyle and the risk of pancreatic cancer in the EPIC study

19. Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers.

20. Re-attendance in supplemental breast MRI screening rounds of the DENSE trial for women with extremely dense breasts

21. Automated rating of background parenchymal enhancement in MRI of extremely dense breasts without compromising the association with breast cancer in the DENSE trial

22. Diagnostic accuracy of supplemental three-dimensional breast ultrasound in the work-up of BI-RADS 0 screening recalls

23. Prophylactic pectoralis major flap to compensate for increased risk of pharyngocutaneous fistula in laryngectomy patients with low skeletal muscle mass (PECTORALIS): study protocol for a randomized controlled trial

25. Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers.

26. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11

27. A Genome-Wide Association Meta-Analysis of Circulating Sex Hormone–Binding Globulin Reveals Multiple Loci Implicated in Sex Steroid Hormone Regulation

29. Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol

31. Cancer detection during the COVID-19 pandemic-Experiences in primary care and recommendations for the future

38. International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries

39. Plasma carotenoids, vitamin C, tocopherols, and retinol and the risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition cohort

40. Vegetable and fruit consumption and the risk of hormone receptor–defined breast cancer in the EPIC cohort

41. Nutrient-wide association study of 92 foods and nutrients and breast cancer risk

42. Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and risk of in situ breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

43. Prospective analysis of circulating metabolites and breast cancer in EPIC

44. Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study

45. Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol

46. Assessing Quantitative Parenchymal Features at Baseline Dynamic Contrast-enhanced MRI and Cancer Occurrence in Women with Extremely Dense Breasts

47. Development and validation of risk calculators for people with 'thin' melanomas on their skin to predict the likelihood that their cancer will return: a plain language summary of publication

48. Validation of Combined Deep Learning Triaging and Computer-Aided Diagnosis in 2901 Breast MRI Examinations From the Second Screening Round of the Dense Tissue and Early Breast Neoplasm Screening Trial

49. Challenges and Changes of the Breast Cancer Screening Paradigm

50. Data from Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC Cohort

Catalog

Books, media, physical & digital resources